CaMaPi for Adolescents/Young People With a History of Self-harm and Suicidal Ideation in Jos, Nigeria

NCT06440031 | Not Yet Recruiting DMC

• 1 other identifier: 0000-0001-5034-0335f
• Study Type: interventional
• Target: 32
• Locations: 0 countries
• Sites: N/A

Brief Summary

Suicide and self-harm are global disease burden that contributes significantly to years of lost life and mortality.

Conditions

Self-harm; Suicidal Ideation

Outcome Measures

Primary Outcomes (1)

• Change in acceptance and satisfaction with the intervention

  Primary outcome measure would be assessed using the Service Satisfaction Scale

  Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention

Secondary Outcomes (6)

• Change in suicidal ideation

  Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention

• Change in hopelessness

  Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention

• Change in Health Status

  Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention

• Change in repetition rate's of self-harm

  Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention

• Change in use of health services

  Change is being assessed from baseline, end of intervention at 12 weeks, and at 12 weeks post-intervention

Study Arms (2)

CaMaPi

EXPERIMENTAL

Behavioral: CaMaPi

TAU

ACTIVE COMPARATOR

Other: TAU

Interventions

CaMaPi BEHAVIORAL

CaMaPi is a manually assisted brief psychological intervention that is based on the principles of Cognitive Behaviour Therapy (CBT). The intervention includes psycho-education and a comprehensive cognitive behavioural assessment of the suicidal ideation and self-harm attempt using virtual stories of four young people to be delivered in 8-10 sessions for over three months

CaMaPi

TAU OTHER

Treatment as Usual (TAU) is routine care, such as diagnosis, assessment, psychotherapy, monitoring and any form of intervention (e.g., medication prescription) available at the collaborating service.

TAU

Eligibility Criteria

• Age: 16 Years - 24 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Patients aged 16-24 years presenting to the participating services, and emergency departments or admitted after an episode of self-harm to the participating hospitals or self-referrals.
• Participants will have to be living within the catchment area of the participating practices, services and hospitals.
• Not needing inpatient psychiatric treatment.

You may not qualify if:

• Severe mental illness (such as Psychotic disorder).
• Conditions limiting engagement with assessment/intervention.
• Temporary resident unlikely to be available for follow up.

Sponsors & Collaborators

• Nottingham Trent University: lead
• University of Manchester: collaborator
• Jos University Teaching Hospital: collaborator
• Teesside University: collaborator

Related Publications (1)

• Jidong DE, Ike TJ, Taru MY, Pwajok JY, Nwoga CN, Jidong JE, Mwankon SB, Francis C, Husain N. Culturally Adapted Manual-Assisted Psychological Intervention (CaMaPI) for Adolescents/Young People With a History of Self-Harm and Suicidal Ideation in Nigeria: A Randomised Controlled Feasibility Trial. Clin Psychol Psychother. 2025 May-Jun;32(3):e70098. doi: 10.1002/cpp.70098.

  PMID: 40497640 DERIVED

MeSH Terms

Conditions

Self-Injurious Behavior; Suicidal Ideation

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Suicide

Central Study Contacts

Dung Jidong, PhD

CONTACT

07448930519; dung.jidong@mamnchester.ac.uk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr

Study Record Dates

• First Submitted: May 28, 2024
• First Posted: June 3, 2024
• Study Start: July 1, 2024
• Primary Completion: June 30, 2025
• Study Completion: September 30, 2025
• Last Updated: June 3, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share